drugset / Trial / NCT04234516
Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder
RandomizedParallel-groupDouble-blindBasic science
Summary
The study aims to examine the effect of buprenorphine on suicidal ideation in individuals with opioid use disorder, and to investigate the functional brain activity related to its potential anti-suicidal effect.
Timeline
- Start
- 2020-01-20
- Primary completion
- 2021-06-10
- Completion
- 2021-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Buprenorphine | Other / unclassified | 8 mg | Subcutaneous |
| Comparator | Morphine | Other / unclassified | 30 mg | Oral |
| Comparator | Naloxone | Small molecule | 2 mg | Subcutaneous |